Themis Medicare Ltd

Themis Medicare Ltd

Themis Medicare Ltd has updated its company secretary/compliance officer's email ID and also updated the email ID of its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited.

Themis Medicare Ltd

Themis Medicare Ltd has published un-audited financial results for the quarter ended June 30, 2026, in the Indian Express and Financials Express newspapers. The results are also available on the company's website.

Themis Medicare Ltd

Themis Medicare Ltd has disclosed the authorized persons for determining materiality of events and making disclosures to stock exchanges under Regulation 30(5) of SEBI (LODR) 2015.

Themis Medicare Ltd

Themis Medicare Ltd has announced the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer, effective August 13, 2026, and the appointment of Mr. Suresh Savaliya as the new Company Secretary, Compliance Officer & KMP, also effective August 13, 2026.

Themis Medicare Ltd

Themis Medicare Ltd has announced the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer, and Key Managerial Personnel (KMP) of the Company, effective August 13, 2026. The Board of Directors also approved the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer, effective the same date. The company has also approved its Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Reports of the Statutory Auditors.

Themis Medicare Ltd

Themis Medicare Ltd has announced unaudited standalone and consolidated financial results for the quarter ended 30th June 2026, along with the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary and Compliance Officer, and the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer, and Key Managerial Personnel.

Themis Medicare Ltd

Themis Medicare Ltd held a board meeting on 13th August 2026, where they approved the un-audited standalone and consolidated financial results for the quarter ended 30th June 2026. The board also approved the resignation of Mr. Nagraj Mogaveera as Interim Company Secretary & Compliance Officer and the appointment of Mr. Suresh Savaliya as Company Secretary, Compliance Officer & Key Managerial Personnel.

Themis Medicare Ltd

Themis Medicare Ltd received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from CTL Trusteeship Ltd regarding the creation of an encumbrance by Vividhmargi Trust over 2,53,17,620 equity shares of Themis Medicare Ltd, constituting 27.49% of the issued and paid-up share capital, in favor of CTL Trusteeship Ltd.

Themis Medicare Ltd

Themis Medicare Ltd has scheduled a Board meeting on 13th August 2026 to consider and approve the standalone and consolidated un-audited financial results for the quarter ended 30th June 2026 and limited review reports of the statutory auditors thereon.

Themis Medicare Ltd

Themis Medicare Ltd has received a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the pledge of 30,00,000 equity shares by Vividhmargi Investments Pvt Ltd.

Themis Medicare Ltd

Themis Medicare Ltd has received a revised disclosure from Vividhmargi Trust regarding the creation of an encumbrance (pledge) of 2,53,17,620 equity shares, representing 27.49% of the company's total share capital, in favor of Kotak Credit Opportunities Fund Trust.

Themis Medicare Ltd

Themis Medicare Ltd has received a revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Vividhmargi Trust regarding the creation of an encumbrance on 2,53,17,620 equity shares of Themis Medicare Ltd on June 29, 2026.

Themis Medicare Ltd

Themis Medicare Ltd has received revised disclosures under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the release of pledge of 15,00,000 equity shares on July 8, 2026.

Themis Medicare Ltd

Themis Medicare Ltd received an email from BSE seeking clarification regarding an increase in volume movement of its securities. In response, the company clarified that there is no pending or delayed disclosure of any material information as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company affirmed that it regularly disseminates all required information and has no new material developments to report that would explain the volume change.

Themis Medicare Ltd

The Bombay Stock Exchange (BSE) has requested a clarification from Themis Medicare Ltd on June 23, 2026, concerning unusual movement observed in its trading volumes. The company's response to this query is currently awaited. This is a routine regulatory query to understand the factors behind the significant trading activity.